TransCode Therapeutics - SEC Filing

Por um escritor misterioso
Last updated 18 novembro 2024
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
RNAZ - Form SC 13D/A - General statement of acquisition of
TransCode Therapeutics - SEC Filing
Technical Analysis of TransCode Therapeutics, Inc. (NASDAQ:RNAZ
TransCode Therapeutics - SEC Filing
EDGAR Filing Documents for 0001104659-21-029169
TransCode Therapeutics - SEC Filing
TransCode Therapeutics Announces Public Offering of Common Stock
TransCode Therapeutics - SEC Filing
Transcode Therapeutics (RNAZ) Stock Rallied 78.5%. Here's Why.
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
TransCode Therapeutics - SEC Filing
EDGAR Filing Documents for 0001104659-21-029169

© 2014-2024 phtarkwa.com. All rights reserved.